Guangzhou Keruite Pharmaceutical Co., Ltd.
Guangzhou Keruite Pharmaceutical Co., Ltd. ("Keruite Pharmaceutical") is a subsidiary of Qixi Group, founded in 2013. It is a modern comprehensive pharmaceutical enterprise integrating R&D, production and marketing. The R&D center is located in Guangzhou High-tech Industrial Development Zone. The self-built factory is located in Yonghe Development Zone, Huangpu District, Guangzhou, covering an area of about 13,000 m2. There are four main buildings: oral solid preparation workshop, API workshop and supporting class A warehouse and environmental protection station.
After years of relentless efforts , the company has built a highly educated research team with strong technological strength, and established a sound GMP and EHS management system. At present, it has successfully overcome the technical barriers of more than ten kinds of antitumor drugs such as lenalidomide, erlotinib, imatinib and sunitinib, and developed API and FDF with its own production advantages.
Bearing the mission of "Life first, quality foundation" in mind, Keruite Pharmaceutical takes"Pursuit of excellence，and better quality to create better health" as the quality policy, and continuously achieves the quality goals. The company obtained the pharmaceutical production license for the first time in 2022, and the current production license covers APIs, tablets and hard capsules, and passed the GMP compliance inspection of tablets and hard capsules in 2023. As a key part of the health industry, the aim of Keruite Pharmaceutical is to reduce the medical costs for cancer patients, provide safe, effective and affordable high-quality drugs for patients, and relieve the medical burden for the country.
Established in 2013
More than 20 company qualification certificates
More than 20 kinds of products (R & D)
More than 50 cooperation medical (scientific research) units
Our Advantage
01
Perfect Facilities
It has a research and development center and built its own factory, and has built four main buildings: oral solid preparation workshop, API workshop and its supporting Class A warehouse and environmental protection station.
02
Strong Team
The company has built a highly educated research team with strong technological strength, and established a sound GMP and EHS management system.
03
Advanced Technology
Successfully overcome the technical barriers of more than ten kinds of antitumor drugs such as lenalidomide, erlotinib, imatinib and sunitinib.
04
Strong Collaboration
Bearing the mission of "Life first, quality foundation" in mind.Keruite Pharmaceutical has established cooperation relations with many well-known scientific research institutions at home and abroad.
Address: Room 803, Building B3, Science and Technology Enterprise Accelerator, No.11 Kaiyuan Avenue, Huangpu District, Guangzhou
Telephone:020-8985 8964
Address: No.80, Spring Equinox Road, Huangpu District, Guangzhou
Telephone:020-8328 9091
Adverse Drug Reaction/Event Feedback E-mail:pvreport@bio-current.com